Probiotics for Weight Control

Composition for reducing body fat content and body weight by regulating intestinal flora using a specific strain of lactobacillus gasseri (MHS-Lga-12) in combination with prebiotics. The composition contains the MHS-Lga-12 strain along with prebiotics like xylitol and skim milk powder. It aims to improve intestinal health and reduce body fat levels by modulating the gut microbiome.

Source

A probiotic composition for treating weight loss conditions like cachexia and wasting syndromes. The composition contains a combination of multiple different bacteria species from genera like Lactobacillus, Enterococcus, and Bifidobacterium. Administering this probiotic mixture allows increased accumulation of white adipose tissue in subjects with weight loss conditions. The specific bacterial strains selected aim to avoid histamine production to mitigate potential negative effects.

Source

A composition of probiotics and prebiotics that can enhance weight loss when used in conjunction with the weight loss drug orlistat. The composition contains specific amounts of resistant dextrin, inulin, corn starch, maltodextrin, and stachyose along with lactic acid bacteria strains like Lactobacillus plantarum, Lactobacillus acidophilus, Bifidobacterium bifidum, and Lactobacillus paracasei.

Source

Enhancing microbiome resilience to improve gut health by administering a combination of fiber and probiotics, especially during times of microbiome stress like a high-fat diet. The fiber and probiotic mixture improves microbiome resilience, intestinal transit, and gut barrier function after a stress like a high-fat, low-fiber diet. Administering this fiber-probiotic blend to subjects undergoing microbiome stressors can prevent or mitigate negative impacts on gut health.

Source

Composition of lactic acid bacteria strains that can reduce body fat, enhance muscle performance and endurance, and reduce fatigue. The strains are Lactobacillus plantarum PL-02, Lactobacillus acidophilus TYCA06, and Lactobacillus casei CS-773. Administering these strains can decrease body weight, promote exercise performance, and enhance body composition.

Source

Probiotic composition with fat-reducing and hypoglycemic properties for preventing and treating obesity and blood sugar issues. The composition contains strains like Pediococcus pentosaceus LN-PT16 along with other probiotics and auxiliary agents. It aims to reduce fat, lower cholesterol, decrease insulin, lower blood sugar, improve glucose tolerance, and reduce weight. The composition can be used in functional foods, supplements, and medications.

Source

Dietary composition that can reduce blood fat and lose weight. The composition comprises chitosan, bifidobacterium longum metaplasia, lactobacillus rhamnosus metazoan, sodium alginate and fruit and vegetable compound.

Source

A combination of two strains of probiotics, Lacticaseibacillus paracasei S38 and Bacillus coagulans BC198, that has been demonstrated to effectively improve body composition and aid in weight loss. The combination of these specific strains shows additive effects compared to administration of each strain alone.

Source

A combination of two probiotic strains, Lacticaseibacillus paracasei S38 and Bacillus coagulans BC198, that effectively improve body compositions by aiding weight loss and reducing body fat. The strains, isolated from human feces and green malt, respectively, have synergistic effects when administered together at lower doses compared to individually. This combination helps inhibit lipogenesis, reduce appetite, increase butyric acid production, and promote beneficial gut bacteria like Akkermansia muciniphila and Ruminococcaceae. It can be used as a probiotic supplement, food, or medication to aid weight loss and body composition improvement.

Source

Probiotic composition and preparation methods for synergistic weight management. The composition contains two specific strains of probiotics, Lab4P, along with dietary fiber, prebiotics, and sweeteners. The probiotics are Lactobacillus acidophilus CUL21, Bifidobacterium animalis subsp. lactis CUL34, Bifidobacterium bifidum CUL20, and Lactobacillus plantarum CUL66. The composition can be formulated into powders, tablets, capsules, and beverages for weight management applications. The strains are combined with fiber, prebiotics, and sweeteners to provide multiple weight management benefits like appetite suppression, cholesterol reduction, and improved gut health.

Source

Modifying the metabolism of probiotic bacteria to reduce lipid absorption and thus regulate body weight. The probiotics are subjected to stress-based directed evolution to develop strains that actively metabolize lipids before being absorbed by the host. The modified probiotics are then administered to overweight or obese subjects to decrease lipid absorption and help manage their weight.

Source

Using human-derived probiotics like Lactobacillus to treat increased gut permeability and metabolic disorders like obesity and diabetes. The disclosure provides methods to reduce intestinal leakiness and inflammation by administering probiotics like Lactobacillus to patients. It also describes increasing ethanolamine metabolism in obese/diabetic patients using probiotics like Lactobacillus rhamnosus strain HL-200. The probiotics can be combined with antidiabetic drugs or weight management drugs.

Source

Novel Bifidobacterium pseudocatenulatum strains PERFECT-2017-0001 and PERFECT-2017-0002, and compositions containing them, for treating obesity, metabolic syndrome, and related conditions. These strains were isolated from a genetically obese child who lost weight and improved clinical markers after consuming a diet enriched with non-digestible carbohydrates. The strains have specific genomic variations related to carbohydrate metabolism that likely contributed their competitive advantage in the changed dietary environment.

Source

A probiotic composition and nutritional composition that can regulate metabolism and improve health. The probiotic composition contains specific strains of bacteria that promote a healthy gut microbiome. The composition includes bifidobacteria, lactobacilli, and other strains. The nutritional composition contains the probiotic composition and other ingredients like prebiotics and proteins. The combination of the probiotic and other ingredients can improve metabolism, reduce body weight, and improve skin health.

Source

Strain of Lactobacillus rhamnosus bacteria that can prevent and treat obesity and diabetes. The strain, called LM1019, inhibits fat cell differentiation and accumulation, reduces appetite, regulates lipid metabolism, and improves glucose metabolism. Administering LM1019 reduced weight gain, body fat, liver fat, blood glucose, insulin, cholesterol, and markers of obesity and diabetes in animal tests.

Source

Strain of bacteria that produce formic acid, which when ingested as a food or supplement can help prevent or treat obesity and metabolic syndrome. The formic acid producing bacteria strain can reduce body weight, inhibit fat accumulation in organs, and lower blood triglyceride and cholesterol levels. The strain can be used in compositions like pharmaceuticals, food, and health supplements.

Source

Probiotic composition to improve wellness and facilitate self-control during restrictive diets. The composition contains a probiotic product from the Lactobacillus genus to prevent, limit, and suppress negative psychological effects associated with restrictive diets like hunger, cravings, and stress. The composition can be used before, during, or after a restrictive diet to make it easier to follow and reduce relapse risks.

Source

Probiotic composition for weight management and stress relief that reduces stress-induced overeating and aids weight loss. The composition contains specific strains of Lactobacillus rhamnosus HA-114, Lactobacillus helveticus R0052, and Bifidobacterium animalis Lafti B94. These strains enhance cognitive control of eating behavior and lipid metabolism to help manage weight and prevent rebound. The composition can be used in foods and beverages for weight loss programs.

Source

A strain of Lactobacillus casei that produces an exopolysaccharide which attenuates markers associated with obesity and related metabolic disorders like non-alcoholic fatty liver disease (NAFLD). The strain can be used as a probiotic to reduce body fat accumulation, block fat absorption from the gut, and prevent/treat obesity and metabolic conditions.

Source

Using the gut bacteria Butyribacter intestini to treat and prevent obesity and obesity-associated diseases like cardiovascular disease and diabetes. strains of Butyribacter intestini can reduce weight gain, lower blood lipids, and improve indicators associated with obesity. The bacteria can be administered alone or in compositions like pharmaceuticals, foods, and beverages. The compositions may contain additional probiotics and prebiotics.

Source

Human-derived Lactobacillus fermentum strains that inhibit lipase activity, preadipocyte differentiation, and triglyceride accumulation and can be used to prevent or treat obesity-related diseases. The strains resist acid and bile, making them suitable for oral administration. The strains can be used in pharmaceuticals, foods, quasi-drugs, and health functional foods for obesity-related diseases.

Source

Composition for prevention, improvement or treatment of obesity or obesity-induced metabolic syndrome containing Enterococcus faecalis as an active ingredient. The composition may contain the strain as an active ingredient at a content of 106 to 1013 cfu/g, a culture having the equal number of live bacteria, or killed bacteria.

Source

Anti-obesity probiotic composition containing specific ratios of six bacterial strains - Bifidobacterium breve, Bifidobacterium longum, Streptococcus salivarius subsp. thermophiles, Lactobacillus acidophilus, Lactobacillus casei, and Lactobacillus delbrueckii. The ratios are 1:1:1:1:1:1. This composition was developed based on gut microbiota from Dusp6 gene knockout mice that resisted diet-induced obesity. The ratios were effective at reducing body weight, fat mass, and adipocyte size while increasing oxygen consumption and energy expenditure in obese mice.

Source

A bacterial composition containing Clostridium strains that can alter the gut microbiota to prevent weight gain and obesity. The composition contains newly identified Clostridium strains, particularly Clostridium XIVa, Clostridium IV, Clostridium anaerovorax, and Lachnospiraceae bacteria. Administering these bacteria increases their abundance in the gut, which suppresses lipid absorption and metabolism genes in the intestine and liver to prevent weight gain.

Source

Probiotic composition containing Lactobacillus salivarius subsp. salicinius AP-32 and Bifidobacterium longum subsp. longum OLP-01 to inhibit fat absorption and treat obesity without undesirable side effects.

Source

Using bacterial proteins to create pharmaceutical and food compositions that induce satiation and prolong satiety in subjects. The proteins are derived from bacteria like E. coli using a protein called ClpB that mimics an appetite-regulating hormone called alpha-MSH. Administering ClpB protein or bacteria expressing ClpB stimulates satiety pathways to reduce food intake. This can be used to promote weight loss and control appetite in obesity.

Source

A nutraceutical or pharmaceutical composition for preventing and treating dysbiosis of the intestinal microbiota. The composition contains a combination of dietary fiber sources, glutamine, probiotics, omega-3 fatty acids, and antioxidants. This holistic approach aims to simultaneously improve intestinal microbiota diversity, permeability, and reduce inflammation and oxidative stress. The composition can be used to prevent and treat conditions associated with dysbiosis like IBS, diabetes, obesity, fatty liver disease, and Crohn's disease.

Source

Postbiotic with slow-carbon fat reduction function for weight management. The postbiotic composition contains specific strains of probiotics, prebiotics, and dietary fiber. It includes 4-7 parts probiotics (Lactobacillus reuteri, Lactobacillus rhamnosus, Streptococcus thermophilus), 45-65 parts prebiotics (stachyose, oligosaccharides, collagen), 10-12 parts Bifidobacterium longum, 13-24 parts polydextrose, 1-3 parts trehalose, 8-17 parts Lactobacillus plantarum (S58), and 73-98 parts dietary fiber. The composition is prepared by mixing the components in specific proportions.

Source

Engineering microbes to produce fatty acid ethanolamides (FAEs) like oleoylethanolamide using sugar feedstocks, and administering the FAE-producing microbes to subjects as a probiotic to treat conditions like obesity or chronic pain. The engineered microbes express enzymes like NAPE synthase and NAPE phospholipase that convert glucose to FAEs like oleoylethanolamide. The microbes are grown in bioreactors to produce surplus FAEs that can be isolated or used directly in a pharmaceutical composition.

Source

A probiotic composition for reducing body fat that contains specific strains of Bifidobacterium bacteria along with prebiotics and dietary fiber. The composition improves body fat rate when consumed. The Bifidobacterium strains are Bifidobacterium longum BB536 and Bifidobacterium breve B-3. The prebiotics are beta glucan. The dietary fiber comes from sources like purple potato powder, mulberry fruit powder, and carrot powder.

Source

Preventing obesity by administering Lactobacillus paracasei AO356 strain to inhibit differentiation of mast cells and reduce fat intake while increasing excretion.

Source

Gut microbes that can reduce obesity by lowering fatty acid levels in the gut fluid. The microbes are from the Lactobacillus, Streptococcus, and Lactococcus genera. They prevent obesity by reducing fatty acid levels in the gut contents, which lowers calorie intake by reducing fat absorption.

Source

Using Lactobacillus plantarum TCI378 and its metabolites to reduce fat formation, enhance fat metabolism, block body fat formation, and improve gastrointestinal functions.

Source

Using a formula containing inulin and beta-glucan to increase Bacteroidetes-to-Firmicutes ratio in the gut microbiome for treating obesity, IBS, ocular diseases such as cataracts and dry eye syndrome, and other conditions.

Source

Lactobacillus paracasei AO356 strain isolated from the human body that inhibits adipogenesis and promotes M2 macrophages to reduce body weight and fat accumulation in animals. The strain can be used as a probiotic, pharmaceutical, or food ingredient to prevent or treat obesity.

Source

Reducing body fat using a probiotic strain called Lactobacillus paracasei subsp paracasei, specifically the strain Lactobacillus paracasei subsp paracasei TCI058. The strain is administered orally to convert fatty acids into conjugated linoleic acid, inhibit fat accumulation, promote fat breakdown, and reduce body fat.

Source

A combination of two probiotic strains, Lacticaseibacillus paracasei S38 and Bacillus coagulans BC198, for effective weight loss and obesity management. The strains when administered together have synergistic benefits like reduced body fat, appetite suppression, increased butyrate production, and altered gut microbiota composition compared to using either strain alone. The probiotic combination can be used in products like supplements, foods, beverages, and medications for weight loss and obesity prevention.

Source

Using a novel strain of Parabacteroides goldsteinii, DSM 32939, for preventing or treating obesity.

Source

Reducing or reversing weight gain associated with antibiotic and antipsychotic medication using a probiotic strain of Lactobacillus reuteri bacteria that produces reutericyclin, a small molecule antimicrobial. Administering the reutericyclin-producing Lactobacillus strain or reutericyclin itself to patients receiving antibiotics or antipsychotics can inhibit or reverse weight gain induced by these medications.

Source

Bacterial strains that have a positive influence on health and prevent or control excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases. The strains are from the Christensenellaceae family and can be harvested from the gut microbiome of overweight or obese individuals. The strains can be used as a medicament to improve factors related to weight and metabolic disorders.

Source

Lactobacillus reuteri bacteria strains isolated from dog saliva that can be used to treat obesity and promote weight loss. Administering the bacteria to mice leads to reduced body weight and fat deposits. The bacteria induce higher oxytocin levels in the mice, and sterile lysed bacteria are sufficient to achieve the physiological effects.

Source

A strain of Bifidobacterium longum that produces a polysaccharide which when administered to mice reduced obesity, fat storage, and fatty liver. The strain could be used to prevent or treat obesity and obesity-related conditions like metabolic syndrome and fatty liver disease. The strain is isolated from a human fecal sample and can be formulated into probiotic products.

Source

A composition and health food for inducing defecation and promoting weight loss. The composition contains natural ingredients like psyllium husk, rice bran, kelp, fructooligosaccharides, chicory fiber, glasswort, yeast, lactulose, lactic acid bacteria, amino acids, Aloe arborescens, and garlic. It provides fiber, nutrients, and compounds that feed beneficial gut bacteria and promote bowel movement and metabolism. The components help proliferate beneficial bacteria, enhance intestinal activity, and prevent toxins.

Source

Using the microbiome of dusp6 deficient animals to identify probiotic bacteria that can be used to alter the gut microbiota to treat or prevent obesity. The method involves collecting gut microbiota from the dusp6 deficient animals and then identifying and isolating the specific bacteria that are responsible for the anti-obesity effects. These bacteria can then be used as probiotics to alter the gut microbiota of obese individuals and treat or prevent obesity.

Source

Composition for treating obesity using probiotics like Bifidobacterium and lactic acid bacteria. The composition is targeted at obese individuals with a specific gut microbiome profile. It contains probiotics for reducing body fat and waist circumference in people with high Firmicutes to Bacteroides ratios in their gut flora. This selective probiotic therapy aims to leverage the gut microbiome's role in obesity to improve treatment outcomes.

Source

A strain of Bifidobacterium animalis subsp. lactis bacteria that reduces body fat and weight when ingested. The strain, named CECT8145, has unique genes compared to other strains that may be responsible for the beneficial effects. It can be formulated into foods and pharmaceuticals to treat and prevent obesity and related diseases.

Source

Administering purified Christensenellaceae bacteria to treat obesity and related conditions. The method involves giving a composition of substantially purified Christensenellaceae bacteria to inhibit weight gain, promote weight loss, and reduce adiposity in a subject. The bacteria can be of the genus Christensenella, like Christensenella minuta.

Source

Using probiotics to regulate body weight by modifying the gut microbiome to impact absorption of dietary lipids. The method involves isolating bacteria from a subject's gut, subjecting them to stress-based directed evolution to generate probiotic strains with modified lipid metabolism, and administering these strains to overweight individuals. The modified probiotics consume more lipids in the gut, reducing the amount available for absorption and aiding weight loss.

Source

Composition for weight management and treatment of obesity, elevated cholesterol, diabetes, hypertension or heart disease. The composition contains three key components: a microbiome modifying component, a satiety modifying component, and a metabolic modifying component. The microbiome modifying component is a prebiotic to beneficially alter gut bacteria. The satiety modifying component promotes feelings of fullness. The metabolic modifying component alters energy metabolism. The composition synergistically targets multiple aspects of weight management.

Source

Composition for weight control containing prebiotics, fibers, tea polyphenols, berries, resveratrol, and a mix of Bifidobacterium lactis B420 and Bifidobacterium breve B-3. The prebiotics have a water activity of 0.1 to improve probiotic stability. The composition aims to control weight, lower blood lipids and blood sugar, and improve intestinal flora.

Source